Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.64 by 3.13 percent. This is a 26.92 percent increase over earnings of $0.52 per share from the same period last year. The company reported quarterly sales of $5.651 billion which missed the analyst consensus estimate of $5.720 billion by 1.21 percent. This is a 6.29 percent increase over sales of $5.317 billion the same period last year.